Abbott Laboratories and AbbVie Inc.

PA 2018 Independent Pharmacies

DOJ False Claims Act Anti Kickback Healthcare Fraud

Penalty

$25 million

Outcome

Abbott Laboratories and AbbVie Inc. to Pay $25 Million to Resolve False Claims Act Allegations of Kickbacks and Off-Label Marketing of the Drug TriCor®

Details

Abbott Laboratories and AbbVie Inc. — DOJ Enforcement (2018)

Outcome: Abbott Laboratories and AbbVie Inc. to Pay $25 Million to Resolve False Claims Act Allegations of Kickbacks and Off-Label Marketing of the Drug TriCor®

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations. Crucible's healthcare compliance layer enforces proper documentation, eligibility verification, and claims accuracy.

Source: DOJ Press Release — Abbott Laboratories and AbbVie Inc. to Pay $25 Million to Resolve False Claims Act Allegations of Kickbacks and Off-Label Marketing of the Drug TriCor

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works